Abbvie Inc

NYSE:ABBV   11:12:30 AM EDT
111.54
+1.49 (+1.35%)
Products

AbbVie Submits Regulatory Applications For SKYRIZI In Psoriatic Arthritis To FDA And EMA

Published: 04/07/2021 13:12 GMT
Abbvie Inc (ABBV) - Abbvie Submits Regulatory Applications for Skyrizi® (risankizumab) in Psoriatic Arthritis to FDA and Ema.